Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...
Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer ...
The UK has just seen the first case of treatment for benign prostatic hyperplasia (BPH) with Rezūm™ Water Vapour Therapy using the newly launched Rezūm™ EVO Console at Basingstoke and North Hampshire ...
U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring(R) Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as ...
While age has always been the strongest risk factor for benign prostatic hyperplasia (BPH), ethnicity and lifestyle factors ...
Discover the innovative minimally invasive surgical techniques (MISTs) reshaping BPH treatment. Learn about benefits, patient ...
New BPH module and clinical data reinforce the TULSA Procedure™’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption ...
For millions of men struggling with an intimate issue, treatments are few and run the risk of life-altering side effects. Benign prostatic hyperplasia (BPH) is a condition that causes chronic and ...
Low-dose pyridostigmine is an effective treatment for men with underactive bladder who undergo TURP for BPH with BOO, trial findings suggest. Administration of pyridostigmine following transurethral ...
An expert discusses how the greatest unmet need in minimally invasive benign prostatic hyperplasia (BPH) treatments is achieving durability and retreatment rates that match those of surgical options ...
PROCEPT BioRobotics Corporation announced that its Aquablation therapy has been assigned a Category I Current Procedural Terminology (CPT) code, which will take effect on January 1, 2026. This marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback